Furthermore, elevated CHI3L1 mRNA expression was observed in gliomas with isocitrate dehydrogenase (IDH) status in wildtype samples (Figure 1C,F), indicating a potential association between CHI3L1 expression and poor clinical outcomes. This evidence concerns the gene CHI3L1 and central nervous system cancer.